Study reveals that inability to drive after using cannabis can last more than five hours

A study published in the Journal of Psychopharmacology contradicts the perception of cannabis users who believe they are fit to drive just a few hours after consuming THC. Contrary to the common assumption that driving ability returns to normal within three hours, researchers found that cannabis-related driving impairments can persist for more than five hours, even when users feel sober and ready to drive. The study involved and followed 38 adults with weekly cannabis use and at least two years of driving experience.

This research highlights the discrepancy between perceived and actual driving ability after cannabis use. With cannabis legalization spreading globally and millions of people using it regularly, these findings have critical implications for public safety, policy, and personal responsibility.

Cannabis use is on the rise – and so are cannabis-related traffic incidents.

In 2021, more than 52 million US citizens reported using cannabis. Concurrently, there has been an increase in traffic accidents involving drivers testing positive for THC. Nevertheless, existing research has struggled to track real-world cannabis use trends and their implications for road safety.

According to the researchers, this study arose from a pressing need to understand how long cannabis actually impairs an individual's ability to drive. Previous studies have predominantly focused on short periods, primarily the first three hours after ingestion. However, this narrow observation window leaves critical blind spots, especially because users often get behind the wheel before their impairments have subsided.

Study structure: A deeper look at driving under the influence of cannabis

To better understand how cannabis affects driving over time, researchers designed a rigorous laboratory experiment. Here's how it worked:

• Participants: 38 healthy adults aged 18 to 40, each with at least two years of highway driving experience and weekly cannabis use.
• Exclusive: This was a randomized, double-blind, placebo-controlled study in which participants participated in three sessions over the course of a full day. Each session involved inhaling a placebo, a low dose of THC (5,9%), or a high dose of THC (13%) using a vaporizer.
• Driving simulations: Participants performed simulated driving tasks at four different times over an eight-hour period. During this time, skills such as lane keeping, following other vehicles, and overtaking were assessed.

Key Findings: Cannabis Impairs Driving Longer Than Users Realize

The results revealed clear and consistent deficiencies across several driving behaviors:

1. Lane Keeping: Reduced Control
   • After a low dose of THC, participants made fewer steering corrections during 3,5h.
   • After a high dose of THC, the deficiencies lasted until 5,5h – far beyond the time that users normally believe is “okay” to drive.
2. Car Following: Slower Reaction Times
   • Participants demonstrated a less consistent use of the accelerator pedal e delayed reactions to three hours after administration of a high dose of THC.
3. Overtaking: Increased risk-taking
   • Participants who ingested high doses sought to perform riskier maneuvers, including choosing narrower spaces between vehicles and the extension of the time spent in the opposite laneThis situation is a clear indicator of a lack of discernment and an increased risk of an accident occurring.

One of the most alarming findings was the gap between perception and actual disability:

• Most participants felt “sober enough to drive” after just two to three hours, although measurable disturbances last much longer.
• About two thirds of users were willing to drive while still objectively impaired – demonstrating the dangers of self-assessed sobriety.

THC blood levels: An unreliable measure of impairment

Another important conclusion raised within the scope of this study calls into question the current legal framework associated with driving under the influence of cannabis:

• Blood and saliva THC concentrations did not reliably predict driving impairment.
• Participants with high THC levels sometimes performed better than those with low THC levels. lower levels, which compromises the use of biological markers to assess disability.

This discovery heightens growing concerns that THC blood limits, often used in legislation regarding driving under the influence of alcohol, do not accurately reflect the ability to drive safely.

Implications for public safety and policy

With cannabis being the second most used recreational substance after alcohol, it is essential to understand its real impact on driving behaviorThis study goes further than previous research:

• Assessment of the effects on a extended period of time.
• Utilization of standardized dosages for all participants.
• Test various dimensions of driving ability, including attention, control and decision-making.

It also reinforces the idea that the subjective sobriety is not reliable and that current THC testing methods may not be sufficient to determine disability in real time.

Limitations: What was missing and what comes next

While the study offers valuable insights, the researchers acknowledged certain limitations:

• A sample size was modest and included few women, older adults, or occasional users, which limits the general applicability of the results.
• The simulated driving conditions, although advanced, cannot fully mimic real-world environments with unpredictable elements such as traffic and weather conditions.

Looking ahead, the research team plans to:

• To incorporate brain imaging techniques (fMRI) to observe how cannabis affects neural activity during driving.
• Investigate the impact of higher concentrations of THC.
• Exploring the effects of tolerance among frequent users.
• Develop alternative assessment instruments beyond biological THC levels for roadside sobriety tests.

Rethinking cannabis, driving, and public awareness

This study conveys a critical message: Cannabis use impairs driving ability for a longer period than most users realize. and subjective perceptions of sobriety can be dangerously misleadingPublic health campaigns should educate users about the risks of driving too soon after using cannabis. Meanwhile, policymakers should to re-evaluate the laws on incapacity based on THC, as well as considering more accurate behavioral and cognitive assessment tools.

As legalization spreads, ensuring road safety requires evidence-based regulations, more ingenious testing methods and a enlightened population who understands that being sober is not synonymous with not being under the influence of cannabis.

____________________________________________________________________________________________________

____________________________________________________________________________________________________

What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!

João Xabregas

More postsBio

With a professional background in CAD technical drawing (2D and 3D), João Xabregas is an activist and advocate for all uses and applications of cannabis. He discovered and entered the world of cannabis during his youth, where he developed a special interest in the cultivation of the plant, which led him on a journey of self-learning through the world of cannabis that continues to this day. His adventures linked to cannabis cultivation began with the same goal as many others: to be able to guarantee the quality and eliminate any possible risks to his health of what he consumed, as well as to avoid any type of dependence on the illicit market. However, he quickly began to view the world of cannabis and everything related to it with a very different perspective. He admits the enormous passion he has for the most persecuted plant in the world and about which he is always willing to write and have a good conversation.

• João Xabregas

  https://cannareporter.eu/author/joaoxabregas/

  Cannabizetol: New cannabinoid may have antioxidant and anti-inflammatory benefits for the skin
• João Xabregas

  https://cannareporter.eu/author/joaoxabregas/

  Systematic review and meta-analysis demonstrate the potential of CBD in reducing seizure frequency in Epilepsy
• João Xabregas

  https://cannareporter.eu/author/joaoxabregas/

  Portugal: New cannabis seizure in Grândola exposes yet another illegal trafficking operation disguised as a medicinal facility
• João Xabregas

  https://cannareporter.eu/author/joaoxabregas/

  SOMAÍ and Universidade Lusófona publish peer-reviewed study to improve practices in the production of full-spectrum cannabis oils